Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 490.35 DKK 2.86% Market Closed
Market Cap: 2.2T DKK

Wall Street
Price Targets

NOVO B Price Targets Summary
Novo Nordisk A/S

There are no price targets for NOVO B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novo Nordisk A/S Competitors:
Price Targets
600062
China Resources Double-Crane Pharmaceutical Co Ltd
36% Upside
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
44% Upside
1666
Tong Ren Tang Technologies Co Ltd
26% Upside
NEU
Neuren Pharmaceuticals Ltd
91% Upside
GLAND
Gland Pharma Ltd
0% Downside
AMIORG
Ami Organics Ltd
39% Upside
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
16% Upside
HITI
High Tide Inc
116% Upside

Revenue
Forecast

Revenue Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's revenue is 13%. The projected CAGR for the next 3 years is 15%.

13%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's operating income is 14%. The projected CAGR for the next 3 years is 14%.

14%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Novo Nordisk A/S

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's net income is 13%. The projected CAGR for the next 3 years is 18%.

13%
Past Growth
18%
Estimated Growth
Estimates Accuracy
5%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NOVO B's stock price target?
Not Available

NOVO B doesn't have any price targets made by Wall Street professionals.

What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's revenue is 13%. The projected CAGR for the next 3 years is 15%.

What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's operating income is 14%. The projected CAGR for the next 3 years is 14%.

What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Novo Nordisk A/S's net income is 13%. The projected CAGR for the next 3 years is 18%.

Back to Top